Slashdot Log In
Anatomy of a Virus
Posted by
ScuttleMonkey
on Sat Feb 04, 2006 06:29 PM
from the candy-inside dept.
from the candy-inside dept.
Roland Piquepaille writes "No, I'm not talking about a computer virus here, but about a real one, the Epsilon 15, which attacks the bacterium Salmonella. By writing a few lines of computer code, biologists from Purdue University have found a way to control a high-resolution microscope. This allowed them to look inside a virus. While previous teams were able to visualize the highly symmetric outer shell of other viruses, these researchers were able to see the whole structure of Epsilon 15, including its tail, its genome and even its core. This better knowledge of viruses which attack bacteria could lead to great advances in medicine, especially when antibiotics become inefficient because of bacteria resisting them."
This discussion has been archived.
No new comments can be posted.
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
I wonder... (Score:5, Interesting)
Re:I wonder... (Score:3, Informative)
See http://en.wikipedia.org/wiki/Bacteriophage_therap
Re:I wonder... (Score:5, Informative)
Rather than having inherent problems with the host's immune system, it seems to have fallen afoul of the Not Invented Here syndrome.
Happily, it looks like this medical technology is coming back out of necessity.
Parent
Re:I wonder... (Score:3, Informative)
Re:I wonder... (Score:1)
What kind of value do you speak of? Economic?
Re:I wonder... (Score:3, Informative)
Re:I wonder... (Score:5, Informative)
Viruses are almost always entirely species specific, mostly because they rely upon the structure of the cells they attack. The structures can include any of the cellular membrane or cell wall, the various DNA transcriptase and polymerase enzymes and the nuclear or chromosomal DNA itself. Bacteria are simple eukaryotic organisms so lack a number of other structures that can be abused by viruses and virus-like agents, and consequently bacteriophages are relatively simple DNA viruses.
Bacteriophages are extremely common, particularly in bacteria-rich open water, especially in plankton-rich parts of the oceans, where there can be much more than 1E10 viruses per litre.
A typical human being will encounter billions of viruses a day, almost none of which will challenge the active immune system -- most will be blocked by the passive systems (the skin, the mucus membranes...).
Bacteriophage therapy bypasses the passive membranes entirely via direct application to an infected wound or by intravenous injection. Since the applied or carefully injected viruses are monoculture and highly species-specific, they do not challenge the body's primary immune response mechanisms except to the extent that any foreign protein in the blood would in dilute amounts.
The important consideration is that the rapidly-responding innate immune system is unlikely to challenge an injected bacteriophage. The viruses cannot infect the host cells and consequently do not distress tissues (danger model and simple phagocyte chemotaxis) and are unlikely to be associated with TLRs in the innate immune system, or even encounter NODs (PAMP/PRR model).
The adaptive immune system is much slower, which is why people are ill for several days when infected with a new pathogen. It essentially exists to memorize successful attacks against serious infectious diseases the host survives, so as to mitigate or prevent future infections by the same (or very similar) microbe.
The plausible risks to the therapeutic bacteriophage itself when introduced into a human being with a normal immune system are mainly that the human's fever and swelling responses triggered by the bacterial infection physically keep the viruses from infecting their target bacteria, or that the human had tissue insulted by a highly similar virus (improperly injected such that it remained at high concentration, perhaps) at some time in the past.
However, the amount of virus to be injected is tunable, and it is much more likely that in the short term the bacteriophages will find, attack and kill most of its target bacteria than they will be wiped out by the patient's immune system.
The major practical problems with bacteriophage therapy is that they are like very narrow-spectrum antibiotics. You need to culture the bacteria in vitro and check its susceptibility to specific virus strains, which can take a full day or more. Moreover, if there are multiple strains of infective bacteria, you can "miss" with the culturing and only partially treat the patient. The time and possibility of "misses" going undetected for a while account for the popularity of wide-spectrum antibiotics.
Unfortunately, wide-spectrum antibiotics are an evolutionary selection pressure on microbes succeptible to them... those that aren't killed because of some inheritable trait are likely to pass that trait onto their offspring. Staph. aureus, a common skin-infection bacterium, is particularly good at this, and there are strains which are resistant to very strong wide-spectrum antibiotics and even some semi-wide-spectrum ones targetting gram-positive bacteria like methicillin and vancomycin -- these are the frightening MRSA and VRSA "superbugs".
The scary thing is that Staph. aureus bacteria are often not the bacteria being treated with wide-spectrum antibiotics like penicillin, so they are overlooked. Survivors may pass on resistance.
Very narrow-spectr
Parent
Re:I wonder... (Score:4, Insightful)
"Forever," probably.
Parent
Re:I wonder... (Score:2, Funny)
Re:I wonder... (Score:2, Informative)
Re:I wonder... (Score:5, Informative)
Depends on who you ask. Some people would say we've done it [phage-biotech.com] already.
Parent
Re:I wonder... (Score:2)
Re:I wonder... (Score:5, Insightful)
Also the genome size has little to do with it. It's not the size, it's the content!
Parent
Re:I wonder... (Score:2)
Re:I wonder... (Score:1, Informative)
I agree that it probably isnt in the interests of big biotech to market such novel treatments as it takes a chunk out of their antibiotic sales. However, if it did work, I bet you some smaller biotech startup would have sprung
Why is this remarkable? (Score:3, Informative)
control those microscopes! (Score:5, Funny)
Re:control those microscopes! (Score:1)
Re:control those microscopes! (Score:2)
They are just behind the curve...
Re:control those microscopes! (Score:1)
Just imagine what a horde of uncontrolled microscopes might have done to the unsuspecting students and staff of Purdue...
bummer ....... (Score:4, Funny)
So they don't look like teh little rocketship diagram we have grown used to all these years.
http://www.ucmp.berkeley.edu/alllife/virus.gif [berkeley.edu]
Re:bummer ....... (Score:2, Informative)
Re:bummer ....... (Score:1)
A few lines of code? wtf? (Score:5, Insightful)
Re:A few lines of code? wtf? (Score:3, Insightful)
Re:A few lines of code? wtf? (Score:2)
Re:A few lines of code? wtf? (Score:4, Informative)
No conventional microscope is involved: A transmission electron microscope is used for this kind of work, with samples that are rapidly cooled to liquid nitrogen temperature to vitrify them. Then complex 3D image reconstruction techniques are used on the images to generate the result.
Typically this involves finding the images of the viruses in the field of view, alignment and centering, similarity clustering of the (grainy) images, averaging of the clusters, determining their relative orientation, 3D reconstruction, and back-projection to compare the result with the input images. Symmetry helps a lot.
Parent
What do they mean, "could lead" ? (Score:5, Informative)
As far as I know, the use of bacteriophages to fight bacterias has been mainstream for years in Russia. A recent article in Science et Vie explained this method and why it was possible to use it : there are so many different bacteriophages that they might outnumber the number of existing bacterias (a good thing, because that implies therefore a kind of competition between viruses, which means the most efficient will emerge in the long run :-) )
The article also explained that what wad actively sought was a bacteriophage attacking Koch bacillas, because some strains are now resistant to the two antibiotics used against them (named here P.A.S. and Rimifon). Once we have located the right bacteriophages killing them, we shall be able to forget antibiotics (viruses, however, might have their own side effects too... Wait and see)
Could be some Nobel prize in the air. I hope it will be granted to the people who deserve it, whoever they are, rather than to other teams just using the ideas of others and presenting them as their owns. The "Not invented here" policy has probaby killed enough people like that :-(
Re:What do they mean, "could lead" ? (Score:5, Interesting)
Mod parent up. The discovery of antibiotics pushed phage research into the background which, I think, many biologists are realizing was a mistake. See Félix d'Herelle [wikipedia.org] for more information.
Parent
Re:What do they mean, "could lead" ? (Score:1)
Most efficient (Score:1)
As others have mentioned, bacteria become resistant to phages too, and a human patient's immune system will produce antibodies against the virus, rendering it much less effective.
Interesting work on nanoscale imaging (Score:4, Informative)
There are some movies of this work in the supplementary info [nature.com] for this article. These illustrate the various "bits" of the Epsilon-15 virus.
It all goes to show that there is some really good work going on in three dimensional imaging of very small things. We're even seeing parts on the inside of these small things - it's just spectacular.
Virus is life (Score:1, Interesting)
Re:Virus is life (Score:3, Informative)
Not really a debate, it depends on your point of view. What sets virii apart from bacteria is that virii can't reproduce by themselves (they abuse other organisms for that). Drop a bunch of virii in an otherwise sterile environment, and nothing much will happen. Drop some bacteria in an otherwise sterile (but suitable) environment, and they'll quickly reproduce. But hey, this is kids biology stuff...
What it looks like under a m
Re:Virus is life (Score:2)
Re:Virus is life (Score:1)
It has NOT been done before, you insensitive clod! (Score:5, Informative)
Also I'm sure they had a very good reason for picking this virus as a first from a virologist point of view, whereas people suggesting they should have picked something 'more important' like AIDS are probably saying that because that's the only virus they know (if they even know the difference between a virus and bacteria - not to mention phage...)
Again a bit of insight, combined with reading TFA in question and perhaps a quick visit to Wikipedia would create much more useful reply comments... (and don't give me any of that "you must be new here" crap...)
Re:It has NOT been done before, you insensitive cl (Score:1)
Re:It has NOT been done before, you insensitive cl (Score:2)
No way! Include those wicked humanimal hybrids that Bush has revealed to us all!
Re:It has NOT been done before, you insensitive cl (Score:2)
Re:It has NOT been done before, you insensitive cl (Score:2, Funny)
You are new here.
Re:It has NOT been done before, you insensitive cl (Score:2)
Really? Looks like a minor variation in image processing software that appears to pull more detail about a small virus. This isn't a revolution in imaging technology. I'm a little curious how the PR people managed to confuse 'control' with 'postprocessing' or 'reconstruction', but not too much. PR people are beyond mere surprise.
Speci
It's Legit (Score:4, Informative)
Keep up the good work ScuttleMonkey.
Re:It's Legit (Score:2)
If they can do this with more virus types they may finally figure out a cure for one. That would be a first for medical science, since they have never found a cure for a single virus yet. Prevention with vaccines is a good thing but having a cure to help those already infected would be better. Think AIDS, everyone that gets it will die unless their body fights it off.
is it just me? (Score:1, Funny)
Will this backfire? (Score:1)
Like the fear of how relying on computers will lead to a scenario like "The Matrix" or "Terminator", what if we become dependant on these viruses and through some stroke of nature, they end up being harmful to us?
The following comment isn't meant to be anti-US, so please don't ta
Re:Will this backfire? (Score:4, Interesting)
These are naturally occuring phages, not genetically engineered super bugs or whatnot. Of course, they are unpatentable in the US, so no one will research them here, although the patent would be unenforcable. "We go out to so-and-so pond, centrifuge the water, isolate phage EB517, dry it and package it into gelatin capsules". Well, just about any grad student could do the same thing.... No bioreactors required, etc.
The US way will be of course to identify a phage that attacks, say, E. Coli H:0157 (and ONLY Ec H:0157! There are too many other beneficial subtypes of E. coli in human guts that shouldn't be killed off...), and then try to do some genetic engineering to it to deliver not only the phage's package but also say a clusterbomb of penicillin or some other antibiotic, to make it "more effective". Then they could generalize from there and get a patent for using the phage for attacking E. Coli bacteria, or even for using phages as antibiotics in humans and livestock. That might get them around the lack of novelness of using phages against bacteria, which already happens in nature.
Parent
Re:Will this backfire? (Score:2, Informative)
However, actually engineering a better delivery mechanism or greater effectiveness could be extremely useful, whether it is promoted by or sim
Does anyone besides me... (Score:1)
All those little-bitty bombs, floating around in your blood stream, looking for a target to impact and go "BOOM!".
Think I'll need a big scotch before I go to bed
WHat about SILVER IONS (Score:2)
Lets just use silver ions to kill virii